Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation
暂无分享,去创建一个
[1] Lars Ridder,et al. Structural elucidation of low abundant metabolites in complex sample matrices , 2013, Metabolomics.
[2] R. Breitling,et al. Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. , 2011, Analytical chemistry.
[3] Lars Ridder,et al. Automatic chemical structure annotation of an LC-MS(n) based metabolic profile from green tea. , 2013, Analytical chemistry.
[4] M. Sevick,et al. Medication nonadherence: a diagnosable and treatable medical condition. , 2013, JAMA.
[5] Roger G. Linington,et al. Molecular networking as a dereplication strategy. , 2013, Journal of natural products.
[6] Ralf J. M. Weber,et al. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics , 2012, Metabolomics.
[7] E. Scapa,et al. Effect of Grapefruit Juice on the Pharmacokinetics of Losartan and Its Active Metabolite E3174 in Healthy Volunteers , 2001, Therapeutic drug monitoring.
[8] Nuno Bandeira,et al. Mass spectral molecular networking of living microbial colonies , 2012, Proceedings of the National Academy of Sciences.
[9] R. Bino,et al. In silico prediction and automatic LC-MS(n) annotation of green tea metabolites in urine. , 2014, Analytical chemistry.
[10] Emma L. Schymanski,et al. Metabolite identification: are you sure? And how do your peers gauge your confidence? , 2014, Metabolomics.
[11] D. Wishart. Advances in metabolite identification. , 2011, Bioanalysis.
[12] J. Xu,et al. Targeted Data-Independent Acquisition and Mining Strategy for Trace Drug Metabolite Identification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry. , 2015, Analytical chemistry.
[13] Donglu Zhang,et al. Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry Data , 2006, Drug Metabolism and Disposition.
[14] M. Barrett,et al. Enhanced Acylcarnitine Annotation in High-Resolution Mass Spectrometry Data: Fragmentation Analysis for the Classification and Annotation of Acylcarnitines , 2015, Front. Bioeng. Biotechnol..
[15] Forest Rohwer,et al. Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures. , 2015, International journal of mass spectrometry.
[16] Donglu Zhang,et al. Mass defect filter technique and its applications to drug metabolite identification by high-resolution mass spectrometry. , 2009, Journal of mass spectrometry : JMS.
[17] W. Niessen,et al. Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry. , 2011, Mass spectrometry reviews.
[18] A. Beresford,et al. Metabolism and kinetics of amlodipine in man. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[19] T. Bjornsson,et al. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans , 1995, Clinical pharmacology and therapeutics.
[20] D. Chace. Mass spectrometry in newborn and metabolic screening: historical perspective and future directions. , 2009, Journal of mass spectrometry : JMS.
[21] Christophe Junot,et al. Annotation of the human adult urinary metabolome and metabolite identification using ultra high performance liquid chromatography coupled to a linear quadrupole ion trap-Orbitrap mass spectrometer. , 2012, Analytical chemistry.
[22] Sebastian Böcker,et al. Computational mass spectrometry for small-molecule fragmentation , 2014 .
[23] B. Misra,et al. Updates in metabolomics tools and resources: 2014–2015 , 2016, Electrophoresis.
[24] Tao Huan,et al. MyCompoundID: using an evidence-based metabolome library for metabolite identification. , 2013, Analytical chemistry.
[25] A. Makarov,et al. Orbitrap mass spectrometry. , 2013, Analytical chemistry.
[26] I. Dasgupta,et al. A Novel 'Dilute-and-Shoot' Liquid Chromatography-Tandem Mass Spectrometry Method for the Screening of Antihypertensive Drugs in Urine. , 2015, Journal of analytical toxicology.
[27] Oliver Fiehn,et al. MS2Analyzer: A Software for Small Molecule Substructure Annotations from Accurate Tandem Mass Spectra , 2014, Analytical chemistry.
[28] R. Kostiainen,et al. Characterization of the in vitro metabolic profile of amlodipine in rat using liquid chromatography-mass spectrometry. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[29] D. Bailey,et al. Grapefruit juice-drug interactions. , 1998, British journal of clinical pharmacology.
[30] L Gillen,et al. Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E‐3174 , 1999, Clinical pharmacology and therapeutics.
[31] I. Piedade,et al. In silico prediction of , 2014 .
[32] Bohumila Suchanová,et al. Liquid chromatography-tandem mass spectrometry in chiral study of amlodipine biotransformation in rat hepatocytes. , 2006, Analytica chimica acta.
[33] Jens M. Rick,et al. Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.
[34] K. Kripalani,et al. Biotransformation of irbesartan in man. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[35] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[36] Pieter C Dorrestein,et al. Illuminating the dark matter in metabolomics , 2015, Proceedings of the National Academy of Sciences.
[37] B. Schmidt,et al. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites. , 2003, Journal of medicinal chemistry.
[38] H. Schiebel,et al. Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. , 2005, Journal of chromatography. A.
[39] M. Eichelbaum,et al. The metabolism of DL-[14C]verapamil in man. , 1979, Drug metabolism and disposition: the biological fate of chemicals.
[40] Oliver Fiehn,et al. Advances in structure elucidation of small molecules using mass spectrometry , 2010, Bioanalytical reviews.
[41] M. Hirai,et al. MassBank: a public repository for sharing mass spectral data for life sciences. , 2010, Journal of mass spectrometry : JMS.
[42] Emma L. Schymanski,et al. Mass spectral databases for LC/MS- and GC/MS-based metabolomics: state of the field and future prospects , 2016 .